21.55

0.19% 0.0352

Avadel Pharmaceuticals Plc (AVDL)

Überblick Nachrichten Preisverlauf Optionskette Financials Warum fällt AVDL? Forum Prognose

Schlusskurs vom Vortag:

$21.51

Offen:

$21.53

24-Stunden-Volumen:

746.32K

Relative Volume:

0.25

Marktkapitalisierung:

$2.11B

Einnahmen:

$221.08M

Nettoeinkommen (Verlust:

$-2.92M

KGV:

-652.88

EPS:

-0.033

Netto-Cashflow:

$5.89M

1W Leistung:

+0.33%

1M Leistung:

-0.14%

6M Leistung:

+91.90%

1J Leistung:

+169.38%

1-Tages-Spanne:

$21.50

$21.56

1-Wochen-Bereich:

$21.48

$21.56

52-Wochen-Spanne:

$6.38

$23.57

Avadel Pharmaceuticals Plc Stock (AVDL) Company Profile

Firmenname

Avadel Pharmaceuticals Plc

Sektor

Healthcare (1120)

Branche

Drug Manufacturers - Specialty & Generic (86)

Telefon

636-449-1830

Adresse

10 EARLSFORT TERRACE, DUBLIN 2

Mitarbeiter

188

Twitter

@AvadelPharma

Nächster Verdiensttermin

2025-03-03

Neueste SEC-Einreichungen

AVDL's Discussions on Twitter

Vergleichen Sie AVDL mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
AVDL Avadel Pharmaceuticals Plc	21.55	2.11B	221.08M	-2.92M	5.89M	-0.033
ZTS Zoetis Inc	124.02	55.12B	9.40B	2.65B	2.24B	5.935
TAK Takeda Pharmaceutical Co Adr	15.96	50.80B	29.63B	260.53M	5.51B	0.0788
HLN Haleon Plc Adr	10.27	45.60B	14.26B	1.98B	2.47B	0.4327
TEVA Teva Pharmaceutical Industries Ltd Adr	31.64	36.04B	16.88B	666.71M	251.19M	0.6132
UTHR United Therapeutics Corp	470.90	20.23B	3.08B	1.24B	1.07B	25.61

Avadel Pharmaceuticals Plc Stock (AVDL) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2025-10-23	Herabstufung	H.C. Wainwright	Buy → Neutral
2025-09-03	Eingeleitet	Wells Fargo	Equal Weight
2025-07-18	Fortgesetzt	H.C. Wainwright	Buy
2025-02-11	Eingeleitet	Deutsche Bank	Buy
2024-06-12	Eingeleitet	Rodman & Renshaw	Buy
2024-03-05	Bestätigt	H.C. Wainwright	Buy
2024-03-05	Bestätigt	Needham	Buy
2024-03-05	Bestätigt	Oppenheimer	Outperform
2024-02-06	Eingeleitet	UBS	Buy
2022-11-30	Hochstufung	Jefferies	Hold → Buy
2022-08-10	Herabstufung	Jefferies	Buy → Hold
2022-07-28	Fortgesetzt	Craig Hallum	Buy
2022-05-26	Herabstufung	Stifel	Buy → Hold
2021-09-23	Eingeleitet	Needham	Buy
2020-07-31	Eingeleitet	Oppenheimer	Outperform
2020-07-21	Eingeleitet	SVB Leerink	Outperform
2020-06-30	Eingeleitet	H.C. Wainwright	Buy
2020-04-03	Eingeleitet	Jefferies	Buy
2020-03-12	Eingeleitet	Stifel	Buy
2020-02-26	Eingeleitet	Piper Sandler	Overweight
2020-01-30	Eingeleitet	Craig Hallum	Buy
2019-06-14	Hochstufung	Ladenburg Thalmann	Neutral → Buy
2019-02-08	Herabstufung	Ladenburg Thalmann	Buy → Neutral

Alle ansehen

Avadel Pharmaceuticals Plc Aktie (AVDL) Neueste Nachrichten

Jan 21, 2026

Avadel Pharmaceuticals Announces Court Hearing for Acquisition - TradingView — Track All Markets

Jan 20, 2026

Avadel (NASDAQ: AVDL) moves Alkermes acquisition forward with Irish court hearing date - Stock Titan

Jan 20, 2026

Jan 19, 2026

State Street Increases Stake in Avadel Pharmaceuticals by 2.39% - Intellectia AI

Jan 19, 2026

Jan 17, 2026

BlackRock discloses 6.94% stake in Avadel Pharmaceuticals By Investing.com - Investing.com Nigeria

Jan 17, 2026

Janus Henderson discloses 1.87% stake in Avadel Pharmaceuticals By Investing.com - Investing.com Nigeria

Jan 17, 2026

Morgan Stanley discloses trading activity in Avadel Pharmaceuticals shares By Investing.com - Investing.com Nigeria

Jan 17, 2026

Bank of America discloses 1.3% stake in Avadel Pharmaceuticals By Investing.com - Investing.com Nigeria

Jan 17, 2026

Bank of America discloses 2.39% stake in Avadel Pharmaceuticals By Investing.com - Investing.com Nigeria

Jan 17, 2026

Jan 16, 2026

TIG Advisors discloses 4.18% stake in Avadel Pharmaceuticals By Investing.com - Investing.com Nigeria

Jan 16, 2026

BlackRock discloses 6.94% stake in Avadel Pharmaceuticals - Investing.com

Jan 16, 2026

Goldman Sachs discloses trading position in Avadel Pharmaceuticals - Investing.com

Jan 16, 2026

Goldman Sachs discloses trading position in Avadel Pharmaceuticals By Investing.com - Investing.com South Africa

Jan 16, 2026

Janus Henderson discloses 1.87% stake in Avadel Pharmaceuticals - Investing.com India

Jan 16, 2026

Bank of America discloses 1.3% stake in Avadel Pharmaceuticals - Investing.com India

Jan 16, 2026

Morgan Stanley discloses trading activity in Avadel Pharmaceuticals shares - Investing.com India

Jan 16, 2026

UBS O’Connor discloses 1.1% stake in Avadel Pharmaceuticals By Investing.com - Investing.com Nigeria

Jan 16, 2026

BlackRock discloses 6.92% stake in Avadel Pharmaceuticals By Investing.com - Investing.com Nigeria

Jan 16, 2026

Bank of America discloses 1.32% stake in Avadel Pharmaceuticals By Investing.com - Investing.com Nigeria

Jan 16, 2026

Morgan Stanley discloses trading in Avadel Pharmaceuticals shares By Investing.com - Investing.com Nigeria

Jan 16, 2026

Morgan Stanley Capital Services discloses Avadel Pharmaceuticals dealings By Investing.com - Investing.com Nigeria

Jan 16, 2026

Jan 15, 2026

Avadel Pharmaceuticals shareholders approve $2.37B takeover bid - The Business Journals

Jan 15, 2026

Sentiment Review: Can Annovis Bio Inc disrupt its industryBond Market & Weekly Setup with High ROI Potential - baoquankhu1.vn

Jan 15, 2026

UBS O’Connor discloses 1.1% stake in Avadel Pharmaceuticals - Investing.com India

Jan 15, 2026

BlackRock discloses 6.92% stake in Avadel Pharmaceuticals - Investing.com

Jan 15, 2026